Quick Answer
REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Operating Income of -$20.20 million for fiscal year 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$20.20M | +34.4% |
| 2024 | -$30.80M | +22.0% |
| 2023 | -$39.50M | -39.9% |
| 2022 | -$28.23M | -179.4% |
| 2021 | -$10.10M | +0.0% |
| 2021 | -$10.10M | -315.0% |
| 2020 | -$2.43M | -235.9% |
| 2020 | -$724.7K | -92.3% |
| 2019 | -$376.9K | -146.7% |
| 2019 | -$152.8K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.03M | +52.4% | +33.6% |
| June 30, 2025 | -$6.07M | +25.3% | +7.1% |
| March 31, 2025 | -$6.54M | +17.5% | +22.7% |
| September 30, 2024 | -$8.46M | +26.8% | -4.1% |
| June 30, 2024 | -$8.13M | +28.3% | -2.6% |
| March 31, 2024 | -$7.92M | -13.4% | +31.5% |
| September 30, 2023 | -$11.56M | -224.6% | -2.0% |
| June 30, 2023 | -$11.34M | -105.4% | -62.3% |
- REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +34.4% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, REVIVA PHARMACEUTICALS HOLDINGS, INC.’s operating income has declined by 13120.9% (from -$152.8 thousand to -$20.20 million).
- The most recent figure is from REVIVA PHARMACEUTICALS HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: